Pennsylvania State Board of Medicine advertising rules — a marketing guide for physicians and practices

What Pennsylvania calls "advertising" — and the false-and-misleading standard

The Pennsylvania definition of advertising is functional: any communication in any medium published by or on behalf of a licensee that promotes, invites or induces patronage of the licensee's professional services. Paid media in every channel qualifies, and so does unpaid content published by or on behalf of the licensee — a practice website, a Google Business Profile, a physician's professional social-media account, review-platform responses, patient-education videos, downloadable guides, webinars, and podcast appearances in a promotional context.

The false-and-misleading standard under 63 P.S. § 422.41(8) and 49 Pa. Code § 16.61 reaches three related failure modes. First, an affirmative false statement — anything that is factually incorrect in a way that a reasonable patient would find material. Second, an omission — leaving out a fact that a reasonable patient would need to interpret the ad correctly. Third, a creation of unjustified expectations — language, imagery or juxtaposition that leads a reasonable patient to expect a favourable outcome that is not typical, not guaranteed, or not clinically indicated for the reader.

The Pennsylvania Board reads the "unjustified expectations" standard broadly. A page that pairs an emotionally-loaded testimonial with a photograph of an idealised body, next to a "book now" call-to-action, creates an unjustified expectation even if every individual statement on the page is technically accurate. The safer construction is non-idealised imagery, testimonial captions that state the technique and the interval, and outcome descriptions expressed in ranges with typicality disclosures.

Credentials, specialties and titles

Pennsylvania takes credentialling claims seriously because they influence a reasonable patient's choice of physician. Three tripwires recur.

• Board certification. "Board-certified" is safe when the certifying body is a member of the American Board of Medical Specialties (ABMS) or the American Osteopathic Association Bureau of Osteopathic Specialists (AOA-BOS). Certifications issued by private organisations that award them for a fee, without a defensible examination and training standard, must be identified by the full name of the certifying body and cannot be shortened to "board-certified".
• Fellowship claims. A "fellowship-trained" claim implies completion of a formal accredited fellowship in the named specialty. Short-course training, weekend workshops, or non-accredited preceptorships do not qualify.
• "Specialising in" and "expert in". These phrases are permissible where the physician has substantial training and practice concentration in the area — and only when they do not imply a certification the physician does not hold. The safer construction describes the training and the practice concentration directly.

Physician-performed versus physician-supervised

Pennsylvania is strict on the distinction between services performed by a physician and services performed by a non-physician under physician supervision. Cosmetic injectables, laser treatments, and aesthetic procedures administered by a registered nurse or physician assistant under supervision cannot be advertised as "administered by our physicians". The safer construction identifies the licensed provider category and the supervising physician by role (not by named individual, unless the physician has consented to be identified in that role in advertising).

Digital advertising — SEO, ads, social, review platforms

Every Pennsylvania rule above applies identically to digital surfaces. Four digital-specific patterns deserve separate calibration.

SEO and AI Overview content

Long-form condition explainers, treatment landing pages, and downloadable guides written for search and generative-AI citation are advertising for Pennsylvania purposes. The State Board of Medicine reviews them against the same false-and-misleading standard as paid media. Author every long-form healthcare page with a byline, a "medically reviewed by" line, a review date, and source citations — the substantiation trail is what a Pennsylvania inspector will look for.

Paid search and paid social

Paid-search creative and paid-social copy are subject to two overlays in addition to Pennsylvania: the ad platform's own healthcare policy, and — for pixel-based tracking — the federal HIPAA rules on disclosure of PHI to third-party trackers. The Pennsylvania-specific point is that the physician remains responsible for every rendered variation, not just the templates. Practices must maintain a review workflow that inspects rendered ads with dynamic-keyword-insertion in place.

Google Business Profile and directory listings

Directory content is advertising in Pennsylvania. Practice descriptions, categories, hours and photographs on GBP, health directories, insurance directories, and physician listings must satisfy the same currency and substantiation controls. A stale profile with a departed physician, an outdated service, or an obsolete credential is deceptive by omission.

Review platforms and responses

The practice's own review response is advertising by the practice. Two failure modes recur. First, confirming a patient's presence in a review response — that is a HIPAA disclosure regardless of what the reviewer wrote. Second, publishing a rebuttal that names or characterises the specific care rendered — again a PHI disclosure. The safe response pattern is a de-identified, standard reply that thanks the reviewer, invites offline discussion, and does not confirm or deny the reviewer's patient status.

Federal overlay — HIPAA, FTC, TCPA, ADA

Pennsylvania advertising rules do not preempt or relax federal requirements. Every campaign has to clear all of them.

• HIPAA Privacy Rule (45 CFR 164). Any advertising that uses PHI requires prior written authorisation. Any third-party tracker on a page that combines an IP address with a condition URL is a disclosure of PHI under the 2022/2024 OCR bulletins.
• FTC Act Section 5. Deceptive or unfair advertising is a federal violation independent of Pennsylvania rules. FTC endorsement guides at 16 CFR 255 govern testimonials nationwide.
• TCPA (47 USC 227). Marketing texts and pre-recorded calls require prior express written consent. Statutory damages are USD 500 to USD 1,500 per unlawful message and aggregate in class actions.
• ADA Title III. Practice websites are places of public accommodation under most federal appellate readings. WCAG 2.2 AA is the operative reference standard, and accessibility failures are increasingly cited alongside deceptive-practice complaints in Pennsylvania.